Black Rock Inc. Collegium Pharmaceutical, Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Black Rock Inc. holds 5,793,383 shares of COLL stock, worth $174 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,793,383
Previous 5,865,899
1.24%
Holding current value
$174 Million
Previous $228 Million
18.08%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
38.6MCall Options Held
100KPut Options Held
21.1K-
Eventide Asset Management, LLC Boston, MA2.64MShares$79.1 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$77.7 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$70.4 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.75MShares$52.4 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$49.7 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.02B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...